Sarasin & Partners’s Doximity DOCS Stock Holding History

Sarasin & Partners’s Portfolio DOCS Stock Details DOCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-60,301	Closed	-$3.5M	–	83
2025 Q1	$3.5M	Buy	+60,301	New	+$3.81M	0.04%	67

Other funds holding DOCS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Sarasin & Partners's DOCS Position: Q2 2025 in Review

Sarasin & Partners sold out of Doximity (DOCS) in Q2 2025, closing a stake of 60,301 shares — an estimated $3.5M sold.

Sarasin & Partners first reported a position in DOCS in Q1 2025 and held it in 1 quarter. The position peaked at $3.5M in Q1 2025. 473 funds tracked by Wall St. Rank hold DOCS as of Q2 2025.

Sarasin & Partners reported no remaining Doximity position as of Q2 2025 after selling out during the quarter.
Sarasin & Partners sold 60,301 Doximity shares in Q2 2025, an estimated $3.5M.
Sarasin & Partners first reported a position in Doximity in Q1 2025 and held it in 1 quarter.
Sarasin & Partners's Doximity position peaked at $3.5M in Q1 2025.
473 funds tracked by Wall St. Rank held Doximity as of Q2 2025.

Based on Sarasin & Partners's 13F filing for Q2 2025, filed 9 Jul 2025.